Harmony Biosciences Holdings (HRMY) Finished Goods (2023 - 2024)
Harmony Biosciences Holdings' (HRMY) quarterly Finished Goods came in at $2.8 million in Q4 2024, up 21.11% year-on-year from $2.3 million in Q1 2024, and down 17.04% quarter-over-quarter from $3.3 million in Q3 2024.
Harmony Biosciences Holdings (HRMY) Finished Goods (2023 - 2024) Analysis & Trends
Harmony Biosciences Holdings has disclosed Finished Goods across 2 years of filings, most recently posting $2.8 million for Q4 2024.
- Finished Goods for Q4 2024 came in at $2.8 million, up 21.11% year-over-year; the trailing twelve-month figure through Dec 2024 was $2.8 million (up 21.11% YoY), and the FY2024 annual result was $2.8 million, up 21.11% from the prior year.
- Finished Goods came in at $2.8 million for Q4 2024 at Harmony Biosciences Holdings, down from $3.3 million in the prior quarter.
- In the past five years, Finished Goods ranged from a high of $3.3 million in Q3 2024 to a low of $2.3 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Harmony Biosciences Holdings | 1.92 Bn | 1.28 Bn | 170.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2.77 Mn |
| Sep 30, 2024 | 3.33 Mn |
| Jun 30, 2024 | 2.76 Mn |
| Mar 31, 2024 | 3.10 Mn |
| Dec 31, 2023 | 2.28 Mn |